Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes

Source : https://cardiab.biomedcentral.com/articles/10.1186/s12933-021-01300-y

Background Transferring results obtained in cardiovascular outcome trials (CVOTs) to the real-world setting is challenging. We herein transposed CVOT results to the population of patients with type 2 diabetes (T2D) seen in routine clinical practice and who may receive the medications tested in CVOTs.